Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$0 Sell
19
-381
-95% -$8.98K ﹤0.01% 2566
2026
Q1
$9K Buy
400
+135
+51% +$3.19K 0.01% 1466
2025
Q4
$7K Buy
265
+262
+8,733% +$7.74K ﹤0.01% 1768
2025
Q3
$0 Sell
3
-1
-25% -$30 ﹤0.01% 2394
2025
Q2
$0 Sell
4
-260
-98% -$8.6K ﹤0.01% 2336
2025
Q1
$10K Buy
264
+260
+6,500% +$11K 0.01% 1483
2024
Q4
$0 Buy
4
+1
+33% +$44 ﹤0.01% 2355
2024
Q3
$0 Hold
3
﹤0.01% 2344
2024
Q2
$0 Hold
3
﹤0.01% 2355
2024
Q1
$0 Hold
3
﹤0.01% 2355
2023
Q4
$0 Sell
3
-1
-25% -$50 ﹤0.01% 2268
2023
Q3
$0 Sell
4
-2
-33% -$117 ﹤0.01% 2244
2023
Q2
$0 Hold
6
﹤0.01% 2256
2023
Q1
$0 Sell
6
-1,637
-100% -$94.9K ﹤0.01% 2158
2022
Q4
$88K Buy
1,643
+683
+71% +$35.2K 0.07% 455
2022
Q3
$44K Buy
960
+643
+203% +$34.9K 0.04% 737
2022
Q2
$17K Sell
317
-955
-75% -$61.6K 0.01% 1017
2022
Q1
$87K Buy
1,272
+697
+121% +$49.7K 0.06% 596
2021
Q4
$45K Buy
+575
New +$48.1K 0.06% 603

Other funds holding ENOV

Covestor's ENOV Position: Q2 2026 in Review

Covestor reduced its Enovis (ENOV) stake by 95% in Q2 2026, selling an estimated $8.98K and leaving 19 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2566.

Covestor first reported a position in ENOV in Q4 2021 and has held it in 19 quarters since. The position peaked at $88K in Q4 2022. 251 funds tracked by Wall St. Rank hold ENOV as of Q2 2026.

  • Covestor held 19 shares of Enovis worth $0 as of Q2 2026.
  • Covestor sold 381 Enovis shares in Q2 2026, an estimated $8.98K.
  • Enovis made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2566 holding.
  • Covestor first reported a position in Enovis in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Enovis position peaked at $88K in Q4 2022.
  • 251 funds tracked by Wall St. Rank held Enovis as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.